Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV003555996 | SCV004300121 | likely pathogenic | not provided | 2023-03-14 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in activation of a cryptic splice site and introduces a premature termination codon (PMID: 16567715). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 9955). This variant is also known as IVS7+5G>A. This variant has been observed in individual(s) with phosphoglycerate kinase 1 deficiency (PMID: 16567715). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 7 of the PGK1 gene. It does not directly change the encoded amino acid sequence of the PGK1 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. |
| OMIM | RCV000010633 | SCV000030859 | pathogenic | Glycogen storage disease due to phosphoglycerate kinase 1 deficiency | 2006-03-28 | no assertion criteria provided | literature only |